Starting from N-substituted indole-3-carboxaldehydes (1a-g) a series of new 3-[(N-substituted indol-3-yl)methyleneamino]-6-amino-4-aryl-pyrano(2,3-c)pyrazole-5-carbonitriles (3a-g and 4a-g) have been synthesized via the acid catalyzed condensation reaction of 1a-g with 3-amino-5-pyrazolone, followed by the reaction with arylidene malononitriles. A series of new 3,6-diamino-4-(N-substituted indol-3-yl)pyrano(2,3-c)pyrazole-5-carbonitriles (7a-g) have been prepared either via the base catalyzed condensation reaction of 1a-g with 3-amino-5-pyrazolone to give 6a-g, followed by the reaction with malononitrile or by the reaction of N-substituted-3-indolylidene malononitriles (5a-g) with 3-amino-5-pyrazolone. According to the obtained results, the newly synthesized compounds possess significant anti-inflammatory, analgesic and anticonvulsant activities. The anticonvulsant potency of certain tested compounds was more pronounced than both anti-inflammatory and analgesic activities. Moreover, most of the newly synthesized compounds possess potential antimicrobial activity against Escherichia coli and Pseudomonas aeruginosa.
Keywords: indole, pyrano(2,3-c)pyrazole, anti-inflammatory, analgesic, anticonvulsant, antimicrobial activity These compounds may be readily obtained from the reaction of 4-aryl methylene--5-pyrazolone and malononitrile (11, 12) or 2-pyrazolin-5-one and benzylidene malononitrile (12) . In the light of these interesting biological activities and also in continuation of our search (5, 6) for compounds potent as anti-inflammatory, analgesic, anticonvulsant agents and antimicrobials, we decided to synthesize some new pyrano(2,3-c)pyrazole-5-carbonitriles, attached directly or through the methyleneamino group bridge to N-substituted indoles at 3-position. EXPERIMENTAL Melting points were determined in open capillary tubes on an Electrothermal 9100 digital melting point apparatus (Büchi, Switzerland) and are uncorrected. Elemental analyses were performed on a Perkin-Elmer 2400 analyzer (Perkin-Elmer, USA) and were found within ± 0.4 % of the theoretical values (Table I) . IR spectra were recorded on a Perkin-Elmer 1600 FTIR (Perkin-Elmer) in KBr discs. 1 H NMR spectra were measured on a Jeol 270 MHz spectrometer (Jeol, Japan) and a Bruker Avance spectrometer (300 MHz) (Bruker, Germany) in DMSO-d 6 , and chemical shifts were recorded in d ppm relative to the internal standard TMS. Mass spectra (EI) were run on a sector-fild mass spectrometer (AMD-Intectra GmbH, Germany) and a gas chromatograph/mass spectrometer, single phase, 200 V, 50/60 Hz, 30 A (Jeol). Spectral data of the synthesized compounds are listed in Table II. The N-substituted indole-3-carboxaldehydes (1a-g) and N-substituted-3-indolylidene malononitriles (5a-g) were prepared as reported, respectively (14, 15) . Synthetic paterns are given in Schemes 1 and 2.
Synthesis. General procedures 3-[(N-substituted-1H-indol-3-yl)methyleneamino]-1H-pyrazol-5(4H)-ones (2a-g
). -A solution of compound 1a-g (0.01 mol) and 3-amino-5-pyrazolone (0.99 g, 0.01 mol) in absolute ethanol (20 mL) containing a few drops of glacial acetic acid was refluxed for 2-3 h. After cooling, the solid that formed was filtered off, washed with water, air dried and recrystallized from ethanol.
3-[(N-substituted-indol-3-yl)methyleneamino]-6-amino-4-(p-fluorophenyl) pyrano(2,3-c)pyrazole-5-carbonitriles (3a-g) and 3-[(N-substituted-indol-3-yl)methyleneamino]-6-amino-4-(p-chlorophenyl)pyrano(2,3-c)pyrazole-5-carbonitriles (4a-g
). -A mixture of compound 2a-g (0.005 mol) and p-fluorobenzylidene malononitrile and/or p-chlorobenzylidene malononitrile (0.005 mol) in absolute ethanol (20 mL) containing triethylamine (0.5 mL) was refluxed for 3-4 h. The formed precipitate hot was filtered off hot, air dried and recrystallized from ethanol.
4-[(N-substituted-indol-3-yl)methylene]-3-amino-1H-pyrazol-5(4H)-ones (6a-g
). -To a stirred solution of 3-amino-5-pyrazolone (0.99 g, 0.01 mol) in absolute ethanol (20 mL) containing triethylamine (0.5 mL), the appropriate N-substituted indole-3-carboxaldehyde (1a-g) (0.01 mol) was added. The reaction mixture was refluxed for 1-4 h. After cooling, the formed solid was filtered off, washed with water, air dried and recrystallized from ethanol. 
3,6-Diamino-4-(N-substituted-indol-3-yl)pyrano(2,3-c)pyrazole-5-carbonitriles (7a-g). Method
A. -A mixture of 3-amino-5-pyrazolone (0.99 g, 0.01 mol) and the appropriate N-substituted-3-indolylidene malononitrile 5a-g (0.01 mol) in absolute ethanol (20 mL) containing triethylamine (0.5 mL) was refluxed for 1-4 h. The formed precipitate was filtered off after cooling, air dried and recrystallized from dioxane. Method B. -To a solution of malononitrile (0.66 g, 0.01 mol) in absolute ethanol (10 mL) and triethylamine (0.5 mL), the appropriate compound 6a-g (0.01 mol) was added. The reaction mixture was refluxed for 3-4 h, and the solid that formed after cooling was filtered off, air dried and recrystallized from dioxane.
Biological assays
Animals. -Adult male albino rats (Harlan Sprague-Dawley), weighing 150-180 g, were used for the evaluation of anti-inflammatory activity. Animals were fasted for 12 hours before the assay. Adult Swiss Webster mice of both sexes (Harlan Sprague-Dawley), weighing 20-25 g, were fasted for 12-24 hours and used for the assessment of analgesic and anticonvulsant activities. All animals were obtained from the animal house colony of the National Research Centre, Cairo, Egypt. Animals were allowed free access to water and were fed a standard diet. Research was conducted in accordance with the ethical rules on animal experimentation, approved by the Ethics Committee of the National Research Centre, Cairo, Egypt. Anti-inflammatory activity. -Evaluation of the anti-inflammatory activity was performed using carrageenean-induced rat's paw oedema model according to the method of Obkowicz et al. (16) . The animals were divided into groups (control, reference and test groups) of 8 animals each. Acute inflammation was produced by subplantar injection of 0.05 mL of 1 % suspension of carrageenean in saline into the plantar tissue of one (right) hind paw of the rat, one hour after oral administration of the test compound at dose levels of 20 and 5 mg kg -1 . The control group received an equal volume of saline into the other (left) hind paw. The reference group was orally administered flufenamic acid (20 mg kg -1 ) and indomethacin (5 mg kg -1 ) suspended in saline as reference drugs. The average mass of oedema was estimated for the control, reference and test groups four hours after drug administration. The inhibitory activity (percentage of inhibition of oedema) was evaluated (17) .
The results were analyzed for statistical significance (expressed as mean ± SEM) between the vehicle control and treated groups using one-way ANOVA followed by multiple comparisons by Duncan's multiple range tests.
Analgesic activity. -It was studied using the p-benzoquinone-induced writhing model in mice according to the method described by Okun et al. (18) . The test compounds and reference drugs flufenamic acid and indomethacine were prepared as a suspension in 2 % Tween 80. A sensitivity test was carried out one day before drug administration when the animals were injected (i.p.) 0.2-0.25 mL of 0.02 % freshly prepared solution of p-benzoquinone in distilled water. Animals showing writhing to p-benzoquinone within 30 minutes were chosen to study the analgesic activity. On the following day, mice were divided into 13 groups of 6 animals each, and the drugs were administered according to One hour latter, a 0.02 % solution of p-benzoquinone was administered (i.p.). The animals were observed for 30 minutes after injection of the irritant, during which time the animals showing writhing were counted (writhing is defined as stretching, torsion to one side, drawing up of hind leg, retraction of the abdomen, so that the mouse belly touches the floor). All writhing is considered as a positive response. The analgesic activity was expressed as percent protection.
Anticonvulsant activity. -The electric shock seizure test (19) was taken as the criterion for the evaluation of anticonvulsant activity. Mice were injected intraperitoneally with 2 % Tween 80 (solvent, negative control) and 5 mg kg -1 diazepam (reference drug). The other groups received two doses (25 and 12.5 mg kg -1 ) of each test compound. One hour after drug administration, animals were stimulated through an ear electrode of 50 mA as a signal stimulator for 0.2 s. The characteristic of electric shock seizure is a tonic limb flexion of 1 to 2 s, followed by a tonic limb extension of roughly 10 to 12 s, and finally generalized clonic movement for 12 s. Only abolishment of the hind limb tonic extensor spasm is recorded as the measure of anticonvulsant potency. The tonic component is considered abolished if the hind leg extension does not exceed a 90°angle with the plane of the body. Animals showing protection against convulsion were counted in each group. The anticonvulsant activity was expressed as percent protection. Antimicrobial evaluation. -Antimicrobial activity of the synthesized compounds was determined in vitro using the disc diffusion method (20) against pathogenic microorganisms: Escherichia coli, Pseudomonas aeruginosa (Gram-negative bacteria), Staphylococcus aureus, Bacillus cereus (Gram-positive bacteria) and one strain of fungi (Candida albicans). They were isolated from clinical samples and identified to the species level according to the API 20E system (Analytab Products, Inc., USA) (bioMerieux, Australia). Antimicrobial activities of the test compounds were estimated by placing presterilized filter paper discs (6 mm in diameter) impregnated with different doses of test compounds (100, 50 and 25 mg per disc) on nutrient and MacConky agar media for bacteria and on Sabouraud dextrose agar for the fungus. Dimethyl formamide (DMF) was used as a solvent for impregnation. Inhibition zones of the tested compounds were measured after 24-48 h. incubation at 37°C for bacteria and after 5 days of incubation at 28°C for fungi. Cefotaxime (CTX), a standardized 30 mg CTX disc was used in the disc diffusion test (Hoechst--Roussel Pharmaceuticals, Germany) and piperacillin (Piperacillin (PIP) 100 mg per disc (Bristol-Myers Squibb, Egypt) were used as reference drugs for bacteria, while nystatin (30 units per disc) (Bristol-Myers Squibb) (unit = 0.04 mg per disc) was used as reference drug for the fungi. The structure of compounds 3a-g and 4a-g was supported by their precise elemental analyses (Table I ) and spectral data (Table II) . As an example, the IR spectrum of compound 4b showed absorption bands at 3291 (NH 2 On the other hand, the base catalyzed Knovenagel reaction of 1a-g with 3-amino--5-pyrazolone yielded the new 4-[(N-substituted-indol-3-yl)methylene]-3-amino-1H-pyrazol-5(4H)-ones (6a-g) in good yields (69-95 %, Scheme 2). Condensation of the latter compounds with malononitrile in refluxing ethanol containing triethylamine led to the formation of new 3,6-diamino-4-(N-substituted-indol-3-yl) pyrano(2,3-c)pyrazole-5-carbonitriles (7a-g) (method A) with the overall yield of 40-68 %. Moreover, compounds 7a-g could also be obtained with an overall yield of 20-47 % via the condensation reaction of N-substituted indole-3-carboxaldehyde (1a-g) with malononitrile to give N-substituted indolylidene malononitriles (5a-g), which reacted with 3-amino-5-pyrazolone in refluxing absolute ethanol containing triethylamine (method B) (Scheme 2). The reaction proceeded via addition of an active methylene group of malononitrile to the ethylenic double bond of compounds 6a-g (method A) or addition of an active methylene group of 3-amino-5-pyrazolone to the ethylenic double bond of compounds 5a-g (method B), followed by intramolecular cyclization and aromatization to give 7a-g. The structure of compounds 7a-g was supported by their elemental analyses (Table  I ) and spectral data (Table II) 
RESULTS AND DISCUSSION

Chemistry
Biological activity
The newly synthesized compounds were evaluated for their anti-inflammatory activity against carrageenean-induced rat's paw oedema by administration of 20 and 5 mg kg -1 (p.o.) using flufenamic acid (20 mg kg -1 ) and indomethacin (5 mg kg -1 ) as reference drugs. The data obtained (Table III) revealed that paw oedema was inhibited by oral administration of most test compounds at a dose level of 20 mg kg -1 . The most active test compounds were in the descending order of 6b, 6g > 3c, 4e > 4d, 7e > 2a, 4b, 4g > 2e, 7d > 3d, 3e, 7g > 4f, 6a > 6e with inhibition effects ranging from 50 to 32 % compared to Analgesic activity of the synthesized compounds was studied using a p-benzoquinone induced writhing response in mice. The obtained data (Table IV) indicated that compounds 2e, 3d, 4g, 6g, 7d and 7g , at a dose of 20 mg kg -1 , showed the same equipotent writhing inhibition of 66 % as indomethacin at a dose of 5 mg kg -1 . On the other hand, the most active test compounds were in the descending order of 2e, 3d, 4g, 6g, 7d, 7g >  2d, 3b, 3g, 4f > 3e, 4e, 6d , 6e, 7e with writhing inhibition of 66, 50 and 42 % compared to flufenamic acid (83 %) at a dose of 20 mg kg -1 . From the data obtained writhing inhibitions of the newly synthesized compounds seem to relate with the presence of halo atoms in these compounds.
Anticonvulsant properties of the tested compounds were studied using the electric shock seizure test. Data obtained (Table V) revealed that compounds 2d, 2e, 3d, 4c, 4f, 4g, 6a and 6d, at a dose level of 25 mg kg -1 , showed anticonvulsant protection (50 %) as did the reference drug diazepam at 5 mg kg -1 , while compounds 3b, 3e, 4d, 6e, 7d and 7e, at a dose level of 25 mg kg -1 exhibited even higher protection (66 to 83 %) than diazepam at 5 mg kg -1 . Compound 4e, at dose levels of 25 and 12.5 mg kg -1 , was found to be the most potent compound as it induced 100 and 66 % protection whereas diazepam (5 mg kg -1 ) caused only 50 % protection against convulsion. It is clear that pyrano(2,3-c) pyrazole compounds 4e and 4d with no chlorine atoms showed higher activity than that with chlorine atoms. Meanwhile, compound 4e (with the chlorine atom at o-position) showed higher protection (100 %) than 4d with chlorine at p-position (83 %). All the newly synthesized compounds were tested for their antimicrobial activity at different doses of test compounds (Table VI) . Compounds 2f, 2g, 6f and 6g, at 100 mg per disc, were found to be the most active of all test compounds with an inhibition zone of 20 mm against E. coli compared to the reference drug cefatoxime (32 mm) at 30 mg per disc and their activity may be associated with the presence of pyrazole moiety at position 3 of indole and existence of the chlorine atom. Compounds 2f, 2g, 3b, 3c, 4c, 4d, 4e , 6d, 6e, 6f, 6g and 7a which contain pyrazole or pyramo(2,3-c)pyranole at position of indole showed potent activity only towards P. aeruginosa with the inhibition zone ranging from 17 to 20 mm compared to cefatoxime (22 mm) at 30 mg per disc and piperacillin (20 mm) at 100 mg per disc. All the test compounds showed slight to moderate activity towards Gram-positive bacteria at 100 mg per disc compared to the reference drug piperacillin.
CONCLUSIONS
A series of new 3-[(N-substituted indol-3-yl)methyleneamino]-6-amino-4-aryl-pyrano(2,3-c)pyrazole-5-carbonitriles (3a-g, 4a-g) and 3,6-diamino-4-(N-substituted-indol-3-yl) pyrano(2,3-c)pyrazole-5-carbonitriles (7a-g) have been synthesized and tested for their anti-inflammatory, analgesic, anticonvulsant and antimicrobial activities. Depending on the obtained results, the newly synthesized compounds with pyrano(2,3-c)pyrazole nucleus at 3-position of indole moiety show anti-inflammatory, analgesic and anticonvulsant activities which are increased by the presence of halo atoms. The anticonvulsant potency of certain tested compounds was more pronounced than both the anti-inflammatory and analgesic activities. Moreover, most of the newly synthesized compounds showed potential antimicrobial activity. 
